Takeaways from #ACC2024. Late breaking trials - take home points @ACCinTouch 1. RELIEVE-HF Trial: In patients with HFrEF and HFpEF, Interatrial Sh
Takeaways from #ACC2024. Late breaking trials - take home points @ACCinTouch 1. RELIEVE-HF Trial: In patients with HFrEF and HFpEF, Interatrial Sh